Agfa HealthCare - Third Quarter 2010

Agfa HealthCareConfirming the positive trend of the previous quarter, Agfa HealthCare's revenue increased 5.5 percent (excluding currency effects: -0.6 percent) compared to the third quarter of 2009. The growth was mainly contributable to the strong performances of both Imaging IT and Enterprise IT.

IT revenue continued its positive trend in the Northern European markets, whereas business in the Southern European countries still suffered from the unstable economic climate. In the emerging countries, Imaging IT continued to perform strongly.

The business group's gross profit margin improved from 38.9 percent in the third quarter of 2009 to 39.7 percent. The improved service efficiency in IT was partially offset by unfavourable raw material conditions. Agfa HealthCare's recurring EBITDA amounted to 39.7 million Euro (or 13.7 percent of revenue). Recurring EBIT improved to 27.7 million Euro, or 9.6 percent of revenue, versus 8.3 percent in the third quarter of 2009.

In the field of healthcare IT (including Imaging Informatics and Enterprise IT), Agfa HealthCare signed over 150 agreements with new customers during the first three quarters of the year. These customers include a wide range of healthcare providers, from large multi-site facilities and regional care providers, to medium sized facilities and imaging centers, spanning a global geographical coverage. Also in IT, Agfa HealthCare announced technology innovations in the fields of Radiology with its IMPAX Data Center solutions, in Cardiology with its IMPAX Cardiology & Heartstation solutions and in the field of Nursing with its ORBIS Care solutions.

In the field of Imaging, Agfa HealthCare announced that it further expanded the geographic availability of the new members of its DX-D offering of direct radiography solutions. Both the DX-D 300 and the DX-D 500n system - now also available in the USA - support a wide range of radiographic exams, while ensuring optimal radiation dose and superb image quality.

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world’s leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,755 million euro in 2009.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2009 were 1,178 million euro. For more information on Agfa HealthCare, please visit www.agfahealthcare.com.

Most Popular Now

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...